539 related articles for article (PubMed ID: 16208597)
41. Angioedema associated with aspirin and rofecoxib.
Marshall LL
Ann Pharmacother; 2005 May; 39(5):944-8. PubMed ID: 15811906
[TBL] [Abstract][Full Text] [Related]
42. Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib.
Bavbek S; Celik G; Ozer F; Mungan D; Misirligil Z
J Asthma; 2004 Feb; 41(1):67-75. PubMed ID: 15046380
[TBL] [Abstract][Full Text] [Related]
43. Hypersensitivity to non-steroidal anti-inflammatory drugs in childhood.
Sánchez-Borges M; Capriles-Behrens E; Caballero-Fonseca F
Pediatr Allergy Immunol; 2004 Aug; 15(4):376-80. PubMed ID: 15305949
[TBL] [Abstract][Full Text] [Related]
44. [Analysis of 76 patients with urticaria and angioedema induced by non-steroidal anti-inflammatory drugs (NSAIDs) in Japan].
Moriya M; Aihara M; Hirota R; Hirata Y; Ikinaga N; Takamura N; Kunimi Y; Uchida T; Ikezawa Z
Arerugi; 2011 Jun; 60(6):699-707. PubMed ID: 21709437
[TBL] [Abstract][Full Text] [Related]
45. Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs.
Quaratino D; Romano A; Di Fonso M; Papa G; Perrone MR; D'Ambrosio FP; Venuti A
Ann Allergy Asthma Immunol; 2000 Jun; 84(6):613-7. PubMed ID: 10875490
[TBL] [Abstract][Full Text] [Related]
46. Patient-reported multiple drug reactions: clinical profile and results of challenge testing.
Ramam M; Bhat R; Jindal S; Kumar U; Sharma VK; Sagar R; Chadda RK
Indian J Dermatol Venereol Leprol; 2010; 76(4):382-6. PubMed ID: 20657119
[TBL] [Abstract][Full Text] [Related]
47. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity.
Sánchez-Borges M; Capriles-Hulett A
Ann Allergy Asthma Immunol; 2000 Jan; 84(1):101-6. PubMed ID: 10674573
[TBL] [Abstract][Full Text] [Related]
48. Floctafenine: a valid alternative in patients with adverse reactions to nonsteroidal anti-inflammatory drugs.
Giuseppe P; Antonino R; Alessandro DB; Donato Q; Marina DF; Donatella P; Francesca G; Alberto V
Ann Allergy Asthma Immunol; 1997 Jan; 78(1):74-8. PubMed ID: 9012626
[TBL] [Abstract][Full Text] [Related]
49. Provocation tests with the offending nonsteroidal anti-inflammatory drugs in patients with urticaria/angioedema reactions.
Zisa G; Riccobono F; Bommarito L; D'Antonio C; Calamari AM; Poppa M; Moschella MA; Di Pietrantonj C; Galimberti M
Allergy Asthma Proc; 2012; 33(5):421-6. PubMed ID: 23026184
[TBL] [Abstract][Full Text] [Related]
50. Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria.
Asero R
Ann Allergy Asthma Immunol; 2000 Aug; 85(2):156-7. PubMed ID: 10982225
[TBL] [Abstract][Full Text] [Related]
51. A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
Williams GW; Kivitz AJ; Brown MT; Verburg KM
Clin Ther; 2006 Feb; 28(2):204-21. PubMed ID: 16678642
[TBL] [Abstract][Full Text] [Related]
52. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
White WB; West CR; Borer JS; Gorelick PB; Lavange L; Pan SX; Weiner E; Verburg KM
Am J Cardiol; 2007 Jan; 99(1):91-8. PubMed ID: 17196469
[TBL] [Abstract][Full Text] [Related]
53. [The epidemiology of adverse reactions to nonsteroidal anti-inflammatory drugs. Nimesulide is tolerated by patients with adverse reactions to NSAIDs and modulates in man the skin response to histamine and codeine].
Astarita C; Franzese A; Sproviero S; Scala G; Ferrara AM; Raucci G; Altucci P
Recenti Prog Med; 1992 Oct; 83(10):567-71. PubMed ID: 1281331
[TBL] [Abstract][Full Text] [Related]
54. Rofecoxib 50 mg and valdecoxib 20 or 40 mg in adults and adolescents with postoperative pain after third molar extraction: results of two randomized, double-blind, placebo-controlled, single-dose studies.
Daniels SE; Desjardins PJ; Bird SR; Smugar SS; Tershakovec AM
Clin Ther; 2006 Jul; 28(7):1022-34. PubMed ID: 16990080
[TBL] [Abstract][Full Text] [Related]
55. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response.
Doña I; Blanca-López N; Cornejo-García JA; Torres MJ; Laguna JJ; Fernández J; Rosado A; Rondón C; Campo P; Agúndez JA; Blanca M; Canto G
Clin Exp Allergy; 2011 Jan; 41(1):86-95. PubMed ID: 21155908
[TBL] [Abstract][Full Text] [Related]
56. Nimesulide and meloxicam are a safe alternative drugs for patients intolerant to nonsteroidal anti-inflammatory drugs.
Senna GE; Passalacqua G; Dama A; Crivellaro M; Schiappoli M; Bonadonna P; Canonica GW
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):393-6. PubMed ID: 14768525
[TBL] [Abstract][Full Text] [Related]
57. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
Daniels S; Robbins J; West CR; Nemeth MA
Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
[TBL] [Abstract][Full Text] [Related]
58. [Intolerance reactions to non-steroidal anti-inflammatory agents (NSA) in adolescents].
Bahemann-Hoffmeister A; Debelić M
Monatsschr Kinderheilkd; 1986 Aug; 134(8):522-6. PubMed ID: 3773919
[TBL] [Abstract][Full Text] [Related]
59. [Allergy and intolerance to nonsteroidal antinflammatory drugs: successful desensitization in three cases].
Cardona R; Ramírez RH; Reina Z; Escobar MF; Morales E
Biomedica; 2009 Jun; 29(2):181-90. PubMed ID: 20128343
[TBL] [Abstract][Full Text] [Related]
60. Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema.
Wong JT; Nagy CS; Krinzman SJ; Maclean JA; Bloch KJ
J Allergy Clin Immunol; 2000 May; 105(5):997-1001. PubMed ID: 10808182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
